Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Scalp Cooling Is Cancer Care
1+ mon, 3+ week ago (497+ words) California Should Cover It Should dignity during chemotherapy be a right, or a privilege reserved for those who can afford it? This legislative session, California has the opportunity to answer that question. Authored by Assemblymember Gregg Hart, AB 1682 would require…...
COOLER HEADS AMMA SYSTEM RECOGNIZED BY AETNA AS MEDICALLY NECESSARY FOR HAIR PRESERVATION DURING CHEMOTHERAPY
2+ mon, 2+ week ago (194+ words) Major National Insurer Confirms Commercial Coverage for Scalp Cooling, Expanding Access for Cancer Patients Nationwide This designation marks a significant milestone in the effort to make scalp cooling accessible to the millions of cancer patients who undergo chemotherapy each year…...
Hair Loss Treatment Market: The Female Majority Nobody Is Serving Yet
2+ mon, 4+ week ago (150+ words) Research Analyst passionate about data & market insights. I turn complex information into clear, actionable strategies. Detail-driven & results-focused — helping businesses make smarter decisions. — Suge Kun Combat-Proven and Export-Ready: How Israel's Avionics Industry Became NATO's Emergency Supplier In December 2025, Germany took delivery…...
ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis
3+ mon, 3+ day ago (84+ words) TradingView ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis AI-driven drug design has enabled rapid, cost-effective development of ABS-201, now in phase II trials for androgenic alopecia and soon for endometriosis. Preclinical…...
Alopecia Areata Market Shifts Toward Biologics as Alternative to JAK Inhibitors
3+ mon, 4+ day ago (163+ words) geneonline.com Alopecia Areata Market Shifts Toward Biologics as Alternative to JAK Inhibitors The market for alopecia areata treatments anticipates steady growth as rising patient awareness and an increased focus on aesthetic self-image drive demand for new therapeutic options. While…...
Connecticut Joins the List of States to Enact Insurance Coverage for Scalp Cooling Therapy
3+ mon, 1+ week ago (258+ words) Paxman Scalp Cooling Logo Connecticut mandates insurance coverage of mechanical scalp cooling effective January 1, 2027 Connecticut enacts insurance coverage for scalp cooling therapy helping reduce financial barriers for cancer patients in managing side effects of chemotherapy HOUSTON, TX, UNITED STATES, June…...
Gen Z men and hair loss: Triggers and tips to prevent it
3+ mon, 2+ week ago (363+ words) Receding hairlines are no longer just a "dad problem." Men in their early 20s and 30s are increasingly reporting excessive hair loss, according to dermatologists. The impact goes beyond appearance. Early hair loss can deeply affect self-esteem, confidence, and mental health in…...
Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India
3+ mon, 4+ week ago (315+ words) MONTRÉAL--(BUSINESS WIRE)--Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced the initiation of its Phase III clinical trial in India evaluating TH07, the…...
Expert Pearls on the Use of the FoLix Laser for Androgenetic Alopecia
4+ mon, 1+ day ago (113+ words) The Dermatology Digest Expert Pearls on the Use of the FoLix Laser for Androgenetic Alopecia With Dr. Jennifer Krejci Jennifer Krejci, MD, a Dermatologist at the Limmer Hair Transplant Center in San Antonio, TX, recently presented new data on FoLix…...
Baricitinib Effective and Safe for Severe Alopecia Areata when Started Early: Study
4+ mon, 4+ day ago (152+ words) Spain: Researchers have found in a real-world prospective study of adults with severe Alopecia Areata that treatment with Baricitinib demonstrated good efficacy and safety over 12 months, particularly when initiated early. In the study, a clinically meaningful response was observed in…...